The Big COVID-19 Update at BioSig Technologies
BioSig Technologies was absolutely crushed on Monday after the company announced that it would be halting its midstage coronavirus study.
All Work
Chris Lange
Atea Pharma Announces Potential Pricing for IPO
Clinical-stage biopharmaceutical company Atea Pharma intends to price 11 million shares for and intial public offering valued up to more than $303 million.
Are Franchise Brands Enough to Lift Hasbro Earnings?
Hasbro reported better than expected quarterly results before the markets opened on Monday, due in part to Star Wars toys.
Apple, Boeing, Caterpillar, Chevron, Microsoft and More Dow Earnings Coming This Week
Roughly a third of the Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.
Amazon, Alphabet, Facebook, Starbucks, Ford, GE, and More Major Earnings Coming This Week
This week will be perhaps the biggest week of earnings season, with many major names reporting, including Amazon, Facebook, Ford and Starbucks.
Why BlondVax Pharma Is Getting Absolutely Crushed
BlondVax Pharma was absolutely crushed on Friday after the company reported late-stage results from its flu vaccine study. Needless to say, results obviously didn’t live up to expectations.
Mattel Is Not Toying Around When It Comes to Earnings
Mattel stock rallied early Friday after it reported better than expected quarterly results late on Thursday.
Gilead Is the First COVID-19 Stock to Win FDA Approval
Gilead Sciences is the first company to cross the finish line for regulatory approval in the fight against the coronavirus.
How American Express Fell Short in Q3
American Express released mixed third-quarter financial results before the markets opened on Friday.
Does Intel Deserve More Credit for Q3 Earnings?
Intel reported its most recent quarterly results after the closing bell on Thursday, but investors weren't happy.
How Coca-Cola Broke Through in Q3
Coca-Cola released better than expected third-quarter financial results before the markets opened on Tuesday.
Are the Bears Taking Over Chipotle After Earnings?
Chipotle earnings were tough on investors stomachs despite a solid beat.
Tesla Does It Yet Again in Q3 With More Record Numbers
Tesla solidifies a leading role in EV companies with this third quarter earnings report.
What to Make of Datto in Its Market Debut
Datto’s shares opened trading above the original initial public offering pricing of $27 per share.
Was iRobot’s Q3 Really That Bad?
iRobot reported its most recent quarterly results after the markets closed on Tuesday. Despite a massive beat, shares were significantly lower.
AmeriHome Announces Potential Price Range for IPO
AmeriHome intends to price more than 14 million shares for an initial public offering valued up to more than $304 million.
The Good, the Bad, the Ugly of Biogen’s Q3
Biogen reported better than expected third-quarter financial results with disappointing guidance before the markets opened on Wednesday.
Snapchat Is Starting to Get the Picture With Q3 Results
Snap Inc. (NYSE: SNAP | SNAP Price Prediction) released third-quarter financial results after markets closed Tuesday. The company reported $0.01 in earnings per share (EPS) and $678.67 million in revenue, compared with consensus estimates…
Why Investors Aren’t Too Keen On Netflix Earnings
Netflix Inc. (NASDAQ: NFLX | NFLX Price Prediction) reported its most recent quarterly results after the closing bell Tuesday. The firm said that it had $1.74 in earnings per share (EPS) and $6.44 billion…
Why This Midstage PTSD Study Is the Real Deal
Aptinyx shares soared on Tuesday after the company provided an update from its midstage study in post-traumatic stress disorder.